Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

| More on:
A happy young couple lie on a wooden deck using a skateboard for a pillow.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With most brokers taking a break over the holiday period, there haven't been many notes hitting the wires.

But never fear! Summarised below are three recent recommendations that remain very relevant today. Here's what brokers are saying about these ASX shares:

Boss Energy Ltd (ASX: BOE)

According to a note out of Bell Potter, its analysts retained their buy rating on this uranium producer's shares with a reduced price target of $4.70. The broker acknowledges that Boss Energy is one of the most shorted shares on the Australian share market. And while it expects the company's costs to come in ahead of expectations, it doesn't believe it will be as bad as short sellers are forecasting. As a result, it thinks short sellers run the risk of being squeezed. So, with its shares screening as incredibly cheap against North American peers, Bell Potter suspects that its shares could re-rate significantly if things go to plan. The Boss Energy share price ended the week at $2.61.

CSL Ltd (ASX: CSL)

A note out of UBS revealed that its analysts retained their buy rating on this biotechnology company's shares with a trimmed price target of $330.00. According to the note, the broker has reduced its earnings estimates and valuation to reflect its belief that trading conditions are not as favourable as hoped for CSL's vaccines business. However, the broker remains bullish on CSL. This is due to the positive outlook for its key CSL Behring plasma business. UBS feels that consensus estimates are achievable, and solid earnings growth is on the way thanks partly to expanding margins. The CSL share price was fetching $283.43 at Friday's close.

Pro Medicus Limited (ASX: PME)

Analysts at Morgan Stanley initiated coverage on this health imaging technology company's shares with an overweight rating and $300.00 price target. According to the note, the broker believes that Pro Medicus has similar qualities to logistics software developer WiseTech Global Ltd (ASX: WTC). Like WiseTech's solutions, Morgan Stanley highlights that Pro Medicus' solutions are very scalable and have relatively low penetration of global markets and low customer churn rates. Morgan Stanley believes this positions Pro Medicus to grow its customer volumes quicker than the industry over the next five years. It is expecting customer volume growth of roughly 7% per annum, whereas it expects the industry to grow at a much lower rate of 2.3% per annum. The Pro Medicus share price was trading at $253.39 on Friday.

Motley Fool contributor James Mickleboro has positions in CSL, Pro Medicus, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

These ASX 200 shares can rise 20% to 50%

Let's see which shares are being tipped to rocket from current levels.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Broker Notes

Why Guzman Y Gomez shares are a sell

Goldman Sachs has given its verdict on the burrito seller.

Read more »

A man pulls a shocked expression with mouth wide open as he holds up his laptop.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A couple makes silly chip moustache faces and take a selfie on their phone.
Broker Notes

Macquarie sees more upside in Telstra shares – What are they worth?

Telstra shares are up 34% over the past year, and Macquarie thinks there's more to come.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

What is Morgans saying about TechnologyOne, Wesfarmers, and Xero shares?

Let's see what the broker is saying about these shares.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Are WiseTech shares a buy after its big acquisition?

Let's see what analysts are saying about this tech stock.

Read more »

ASX 200 shares broker downgrade origami paper fortune teller with buy hold sell and dollar sign options
Broker Notes

Are Bendigo Bank shares a buy, hold or sell? Here's Macquarie's latest recommendation

Should I buy the dip on Bendigo Bank shares today?

Read more »

Happy man working on his laptop.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »